Barbara Wirostko

Barbara joined EyeGate in conjunction with its March 2016 acquisition of Jade Therapeutics, where she was a co-founder and served as Chief Scientific Officer since the Company’s inception in 2012. She is a former Senior Medical Director at Pfizer, where she led a successful EU regulatory EMA filing for Xalatan in pediatric glaucoma. She is a board certified ophthalmologist and a fellow of the American Academy of Ophthalmology. In addition to her role at EyeGate, Barbara Wirostko maintains an academic research and clinical practice with the University of Utah, Moran Eye Center, as a Clinical Adjunct Associate Professor in Ophthalmology and as an Adjunct Associate Professor of Bioengineering. Barbara Wirostko holds an M.D. from and completed her residency training at Columbia University, and holds a Bachelor’s Degree in Microbiology (with distinction) from Cornell University.

Barbara Wirostko is the Co-Founder and Chief Medical Officer at Qlaris Bio, based in United States, North America. With a background in Biotechnology, Barbara Wirostko has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.